Dr. Chakri Gavva, MD

Dr. Gavva practices at Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services.

Dr. Gavva's NPI, 1821432089, was assigned on April 18, 2013. Dr. Gavva holds New Mexico license MD2018-0074.

Dr. Gavva's primary practice is Presbyterian Hospital, at 1100 Central Avenue SE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 724-8386.

Dr. Gavva's primary practice is Presbyterian Hospital in Albuquerque, New Mexico, part of Presbyterian Healthcare Services. Dr. Gavva is also affiliated with Presbyterian Santa Fe Medical Center. The medical group on file is Presbyterian Medical Group. Dmand AI also links Dr. Gavva to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Gavva's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gavva practices, 3 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Gavva's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Gavva is licensed in New Mexico.

CMS data shows 76 Medicare services from Dr. Gavva across 4 procedure codes in 2024, for 104 Medicare patients. Medicare paid $2,780 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 104 Medicare patients who saw Dr. Gavva in 2024. The largest group is 65 to 74, with 45 patients. 69% of them have high cholesterol, and 63% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.01, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gavva's median patient age at 56, with 81% women.

In 2024, Dr. Gavva wrote 190 Medicare Part D claims for 33 patients. CMS names the drug for 179 of them, across 3 drugs with 11 or more claims each, at $124,077 in total drug cost. In 2023, CMS named 115 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Gavva for performance year 2024, reported as part of a group. Dr. Gavva accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gavva as offering telehealth.

CMS Open Payments shows 40 general payments to Dr. Gavva from 16 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Daiichi Sankyo Inc. paid the most, $310.